Further, IL-17A stimulation of primary B cells from non-Hodgkin lymphomas promoted proliferation in vitro, while stimulation also enhanced tumor proliferation and angiogenesis in vivo (60). The gene discussed is IL17A; the disease is non-Hodgkin lymphoma.